CN Stock MarketDetailed Quotes

Shenyang Xingqi Pharmaceutical (300573)

Watchlist
  • 67.09
  • +0.74+1.12%
Market Closed May 15 15:00 CST
16.53BMarket Cap21.86P/E (TTM)

Shenyang Xingqi Pharmaceutical (300573) Income Statement

All
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q9)Sep 30, 2025
(Q6)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
Total operating revenue
27.45%683.34M
27.24%2.47B
32.27%1.9B
30.38%1.16B
53.24%536.14M
32.42%1.94B
30.27%1.44B
30.10%891.8M
22.10%349.88M
17.42%1.47B
Operating revenue
27.45%683.34M
27.24%2.47B
32.27%1.9B
30.38%1.16B
53.24%536.14M
32.42%1.94B
30.27%1.44B
30.10%891.8M
22.10%349.88M
17.42%1.47B
Other operating revenue
----
2.20%19.92M
----
8.95%12.65M
----
-30.06%19.49M
----
-18.82%11.61M
----
20.08%27.86M
Total operating cost
24.37%456.99M
8.00%1.67B
9.79%1.22B
12.33%779.97M
17.29%367.43M
28.73%1.54B
23.05%1.11B
18.27%694.36M
19.36%313.25M
18.25%1.2B
Operating cost
15.27%122.64M
10.65%465.96M
14.25%355.47M
15.39%224.7M
27.25%106.4M
26.82%421.11M
25.61%311.14M
20.15%194.73M
21.42%83.61M
24.99%332.06M
Operating tax surcharges
21.02%9.24M
29.13%32.83M
35.94%26.88M
36.88%16.27M
88.30%7.64M
54.91%25.42M
57.42%19.77M
50.56%11.89M
52.81%4.06M
4.95%16.41M
Operating expense
18.80%199.6M
8.29%763.97M
7.46%555.47M
10.48%366.1M
12.00%168.01M
31.79%705.49M
25.90%516.89M
21.93%331.38M
11.98%150.01M
15.51%535.31M
Administration expense
11.76%41.75M
2.50%174.55M
-1.07%118.94M
-1.02%77.9M
-3.46%37.36M
10.23%170.29M
6.84%120.23M
10.62%78.69M
28.60%38.7M
17.08%154.49M
Financial expense
-176.13%-724.26K
335.68%4.25M
2,613.77%3.91M
410.29%3.24M
179.65%951.34K
115.66%974.81K
96.85%-155.63K
70.26%-1.04M
34.45%-1.19M
23.06%-6.23M
-Interest expense (Financial expense)
-67.92%481.32K
-22.35%4.44M
-6.46%3.8M
23.92%2.8M
147.88%1.5M
297.30%5.71M
398.48%4.07M
560.16%2.26M
284.14%605.37K
53.38%1.44M
-Interest Income (Financial expense)
43.20%-408.35K
60.18%-2.25M
60.98%-1.85M
61.86%-1.39M
61.11%-718.88K
28.51%-5.66M
19.81%-4.75M
7.64%-3.65M
9.55%-1.85M
20.34%-7.91M
Research and development
79.46%84.47M
2.38%225.91M
11.21%155.12M
16.59%91.76M
23.65%47.07M
31.90%220.66M
14.75%139.48M
1.28%78.7M
32.72%38.07M
14.89%167.3M
Credit Impairment Loss
-42.07%-526.82K
52.94%-2.17M
-46.17%-4.78M
67.87%-1.15M
-131.18%-370.83K
-23.77%-4.62M
25.05%-3.27M
20.03%-3.58M
199.72%1.19M
-263.51%-3.73M
Asset Impairment Loss
99.52%-30.63K
-344.17%-15.18M
-150.89%-7.77M
-339.93%-7.64M
-463.56%-6.4M
58.81%-3.42M
-12.44%-3.1M
32.74%-1.74M
134.36%1.76M
-88.28%-8.29M
Other net revenue
-33.98%6.23M
-33.47%16.84M
-23.74%15.54M
15.32%13.02M
-11.22%9.44M
205.09%25.31M
195.14%20.38M
289.58%11.29M
949.02%10.63M
-42.65%8.3M
Invest income
----
----
----
----
----
---24.24K
---24.24K
---24.24K
----
----
Asset deal income
----
105.37%52.54K
-26.66%74.56K
-51.62%74.8K
--32.1K
-2,506.63%-978.36K
421.82%101.67K
589.43%154.62K
----
-108.92%-37.53K
Other revenue
-58.04%6.79M
-0.62%34.14M
5.04%28.01M
31.94%21.74M
110.64%16.18M
68.71%34.35M
89.79%26.66M
65.02%16.48M
51.66%7.68M
4.53%20.36M
Operating profit
30.55%232.58M
93.58%822.22M
99.67%703.47M
89.61%395.79M
277.02%178.15M
53.61%424.75M
66.33%352.31M
106.09%208.74M
106.63%47.25M
10.56%276.52M
Add:Non operating Income
1,004.97%10K
77.21%517.25K
-25.70%183.76K
232.97%83.76K
--905
205.45%291.89K
189.07%247.33K
-67.57%25.16K
----
-96.84%95.56K
Less:Non operating expense
302.88%2.47M
-25.15%22.46M
1.25%14.88M
32.40%11.17M
-89.05%612.66K
158.22%30.01M
59.56%14.7M
1.67%8.44M
408.65%5.6M
-40.12%11.62M
Total profit
29.62%230.12M
102.59%800.28M
103.86%688.77M
92.04%384.71M
326.19%177.53M
49.07%395.03M
66.69%337.86M
115.26%200.33M
90.40%41.66M
13.38%264.99M
Less:Income tax cost
-25.08%23.71M
83.29%104.42M
90.81%89.86M
60.88%49.88M
358.07%31.64M
128.27%56.97M
131.32%47.1M
484.20%31M
173.19%6.91M
13.27%24.96M
Net profit
41.48%206.41M
105.84%695.86M
105.98%598.91M
97.75%334.83M
319.86%145.9M
40.84%338.06M
59.47%290.76M
92.95%169.32M
79.59%34.75M
13.39%240.04M
Net profit from continuing operation
41.48%206.41M
105.84%695.86M
105.98%598.91M
97.75%334.83M
319.86%145.9M
40.84%338.06M
59.47%290.76M
92.95%169.32M
79.59%34.75M
13.39%240.04M
Net profit of parent company owners
41.48%206.41M
105.84%695.86M
105.98%598.91M
97.75%334.83M
319.86%145.9M
40.84%338.06M
59.47%290.76M
92.95%169.32M
79.59%34.75M
13.39%240.04M
Earning per share
Basic earning per share
42.37%0.84
105.07%2.83
105.04%2.44
97.10%1.36
195.00%0.59
0.00%1.38
13.33%1.19
35.29%0.69
25.00%0.2
-19.77%1.38
Diluted earning per share
42.37%0.84
105.07%2.83
105.04%2.44
97.10%1.36
195.00%0.59
0.00%1.38
13.33%1.19
35.29%0.69
25.00%0.2
-19.77%1.38
Other composite income
1.42M
Other composite income of parent company owners
----
--1.42M
----
----
----
----
----
----
----
----
Total composite income
41.48%206.41M
106.26%697.27M
105.98%598.91M
97.75%334.83M
319.86%145.9M
40.84%338.06M
59.47%290.76M
92.95%169.32M
79.59%34.75M
13.39%240.04M
Total composite income of parent company owners
41.48%206.41M
106.26%697.27M
105.98%598.91M
97.75%334.83M
319.86%145.9M
40.84%338.06M
59.47%290.76M
92.95%169.32M
79.59%34.75M
13.39%240.04M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q9)Sep 30, 2025(Q6)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023
Total operating revenue 27.45%683.34M27.24%2.47B32.27%1.9B30.38%1.16B53.24%536.14M32.42%1.94B30.27%1.44B30.10%891.8M22.10%349.88M17.42%1.47B
Operating revenue 27.45%683.34M27.24%2.47B32.27%1.9B30.38%1.16B53.24%536.14M32.42%1.94B30.27%1.44B30.10%891.8M22.10%349.88M17.42%1.47B
Other operating revenue ----2.20%19.92M----8.95%12.65M-----30.06%19.49M-----18.82%11.61M----20.08%27.86M
Total operating cost 24.37%456.99M8.00%1.67B9.79%1.22B12.33%779.97M17.29%367.43M28.73%1.54B23.05%1.11B18.27%694.36M19.36%313.25M18.25%1.2B
Operating cost 15.27%122.64M10.65%465.96M14.25%355.47M15.39%224.7M27.25%106.4M26.82%421.11M25.61%311.14M20.15%194.73M21.42%83.61M24.99%332.06M
Operating tax surcharges 21.02%9.24M29.13%32.83M35.94%26.88M36.88%16.27M88.30%7.64M54.91%25.42M57.42%19.77M50.56%11.89M52.81%4.06M4.95%16.41M
Operating expense 18.80%199.6M8.29%763.97M7.46%555.47M10.48%366.1M12.00%168.01M31.79%705.49M25.90%516.89M21.93%331.38M11.98%150.01M15.51%535.31M
Administration expense 11.76%41.75M2.50%174.55M-1.07%118.94M-1.02%77.9M-3.46%37.36M10.23%170.29M6.84%120.23M10.62%78.69M28.60%38.7M17.08%154.49M
Financial expense -176.13%-724.26K335.68%4.25M2,613.77%3.91M410.29%3.24M179.65%951.34K115.66%974.81K96.85%-155.63K70.26%-1.04M34.45%-1.19M23.06%-6.23M
-Interest expense (Financial expense) -67.92%481.32K-22.35%4.44M-6.46%3.8M23.92%2.8M147.88%1.5M297.30%5.71M398.48%4.07M560.16%2.26M284.14%605.37K53.38%1.44M
-Interest Income (Financial expense) 43.20%-408.35K60.18%-2.25M60.98%-1.85M61.86%-1.39M61.11%-718.88K28.51%-5.66M19.81%-4.75M7.64%-3.65M9.55%-1.85M20.34%-7.91M
Research and development 79.46%84.47M2.38%225.91M11.21%155.12M16.59%91.76M23.65%47.07M31.90%220.66M14.75%139.48M1.28%78.7M32.72%38.07M14.89%167.3M
Credit Impairment Loss -42.07%-526.82K52.94%-2.17M-46.17%-4.78M67.87%-1.15M-131.18%-370.83K-23.77%-4.62M25.05%-3.27M20.03%-3.58M199.72%1.19M-263.51%-3.73M
Asset Impairment Loss 99.52%-30.63K-344.17%-15.18M-150.89%-7.77M-339.93%-7.64M-463.56%-6.4M58.81%-3.42M-12.44%-3.1M32.74%-1.74M134.36%1.76M-88.28%-8.29M
Other net revenue -33.98%6.23M-33.47%16.84M-23.74%15.54M15.32%13.02M-11.22%9.44M205.09%25.31M195.14%20.38M289.58%11.29M949.02%10.63M-42.65%8.3M
Invest income -----------------------24.24K---24.24K---24.24K--------
Asset deal income ----105.37%52.54K-26.66%74.56K-51.62%74.8K--32.1K-2,506.63%-978.36K421.82%101.67K589.43%154.62K-----108.92%-37.53K
Other revenue -58.04%6.79M-0.62%34.14M5.04%28.01M31.94%21.74M110.64%16.18M68.71%34.35M89.79%26.66M65.02%16.48M51.66%7.68M4.53%20.36M
Operating profit 30.55%232.58M93.58%822.22M99.67%703.47M89.61%395.79M277.02%178.15M53.61%424.75M66.33%352.31M106.09%208.74M106.63%47.25M10.56%276.52M
Add:Non operating Income 1,004.97%10K77.21%517.25K-25.70%183.76K232.97%83.76K--905205.45%291.89K189.07%247.33K-67.57%25.16K-----96.84%95.56K
Less:Non operating expense 302.88%2.47M-25.15%22.46M1.25%14.88M32.40%11.17M-89.05%612.66K158.22%30.01M59.56%14.7M1.67%8.44M408.65%5.6M-40.12%11.62M
Total profit 29.62%230.12M102.59%800.28M103.86%688.77M92.04%384.71M326.19%177.53M49.07%395.03M66.69%337.86M115.26%200.33M90.40%41.66M13.38%264.99M
Less:Income tax cost -25.08%23.71M83.29%104.42M90.81%89.86M60.88%49.88M358.07%31.64M128.27%56.97M131.32%47.1M484.20%31M173.19%6.91M13.27%24.96M
Net profit 41.48%206.41M105.84%695.86M105.98%598.91M97.75%334.83M319.86%145.9M40.84%338.06M59.47%290.76M92.95%169.32M79.59%34.75M13.39%240.04M
Net profit from continuing operation 41.48%206.41M105.84%695.86M105.98%598.91M97.75%334.83M319.86%145.9M40.84%338.06M59.47%290.76M92.95%169.32M79.59%34.75M13.39%240.04M
Net profit of parent company owners 41.48%206.41M105.84%695.86M105.98%598.91M97.75%334.83M319.86%145.9M40.84%338.06M59.47%290.76M92.95%169.32M79.59%34.75M13.39%240.04M
Earning per share
Basic earning per share 42.37%0.84105.07%2.83105.04%2.4497.10%1.36195.00%0.590.00%1.3813.33%1.1935.29%0.6925.00%0.2-19.77%1.38
Diluted earning per share 42.37%0.84105.07%2.83105.04%2.4497.10%1.36195.00%0.590.00%1.3813.33%1.1935.29%0.6925.00%0.2-19.77%1.38
Other composite income 1.42M
Other composite income of parent company owners ------1.42M--------------------------------
Total composite income 41.48%206.41M106.26%697.27M105.98%598.91M97.75%334.83M319.86%145.9M40.84%338.06M59.47%290.76M92.95%169.32M79.59%34.75M13.39%240.04M
Total composite income of parent company owners 41.48%206.41M106.26%697.27M105.98%598.91M97.75%334.83M319.86%145.9M40.84%338.06M59.47%290.76M92.95%169.32M79.59%34.75M13.39%240.04M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More